VOLUME 13 | NUMBER 5 | MAY 2010 nature neurOSCIenCe a r t I C l e S Signaling gain in a neuronal network can be maintained during longlasting activity alterations by homeostatic compensation of synaptic strengths 1 . However, unchecked global homeostatic scaling of synapses may destabilize a network as a result of complexities in realistic circuits [2] [3] [4] . As a compromise between gain and stability, subsets of circuits are often maintained by adaptations opposite to simple homeostatic scaling [4] [5] [6] [7] . A complete understanding of adaptive plasticity requires that we know how subsets of synapses can diverge from conventional homeostatic adaptations.
a r t I C l e S
Signaling gain in a neuronal network can be maintained during longlasting activity alterations by homeostatic compensation of synaptic strengths 1 . However, unchecked global homeostatic scaling of synapses may destabilize a network as a result of complexities in realistic circuits [2] [3] [4] . As a compromise between gain and stability, subsets of circuits are often maintained by adaptations opposite to simple homeostatic scaling [4] [5] [6] [7] . A complete understanding of adaptive plasticity requires that we know how subsets of synapses can diverge from conventional homeostatic adaptations.
In a conventional homeostatic procedure, days-long inactivity strengthens excitatory synapses and weakens inhibitory synapses for compensatory boosting of net excitability 1, 8 . Therefore, changes in synaptic strengths opposite to the conventional ones could be classified as inverse-homeostatic scaling, such as inactivity-induced decreases in glutamatergic transmission or increases in GABA transmission. For example, a CA3 microcircuit can be stabilized by inversehomeostatic downregulation of recurrent glutamatergic synapses 4 . Optimal efficiency of hippocampal circuits after inactivity can also be achieved by balanced strengthening of both excitatory and inhibitory synapses, with the latter effect representing an inverse-homeostatic change [5] [6] [7] . The accumulating evidence for inverse-homeostatic changes being critical for local network adaptations necessitates a better understanding of the mechanisms involved.
Given the functional diversity of hippocampal interneurons, a global and uniform synaptic scaling might not suffice for homeostatic maintenance of the inhibitory circuits. This led us to examine the specificity of homeostatic plasticity at inhibitory synapses, focusing on the role of endocannabinoids, which directly regulate only GABAergic terminals that contain cannabinoid receptor type 1 (CB1Rs). We hypothesized that an inactivity-induced change in endocannabinoid function mediates homeostasis of CB1R-positive inhibitory synapses, perhaps in parallel with global and conventional synaptic scaling. Endocannabinoids, anandamide and 2-arachidonoyl glycerol (2-AG), are produced in response to a rise in Ca 2+ and/or activation of G proteins and suppress synaptic transmission by binding to presynaptic CB1Rs 9, 10 . Several properties of the endocannabinoids and CB1R led us to postulate their involvement in the adaptation of inhibitory circuits. First, most CB1Rs in the hippocampus are expressed on GABAergic terminals that contain cholecystokinin but not parvalbumin 11, 12 . Second, CB1Rs undergo long-lasting changes when neuronal activity is altered by epilepsy 13, 14 or by chronic application of CB1R agonists 15, 16 . Third, the action of endocannabinoids is very local and specific because of temporal and spatial limitations on their production and extracellular spread. Fourth, endocannabinoids are produced in proportion to the degree of neuronal activity; thus, the endocannabinoid system is ideally suited to serve the demands of homeostasis, an activity-dependent process. We studied adaptive plasticity of inhibitory transmission in hippocampal slice cultures, which preserve realistic circuits but are amenable to long-term manipulations.
We found that the release probability (P r ) of GABA at CB1R-positive inhibitory synapses was augmented after chronic activity deprivation induced by tetrodotoxin (TTX). The inactivity-induced strengthening of GABAergic synapses was mediated by reduced tonic action of anandamide, rather than 2-AG. Anandamide tone was decreased by upregulation of transport and degradation. a r t I C l e S neuronal firing was blocked with 1 µM TTX for 3-5 d. The mean amplitude of miniature inhibitory postsynaptic currents (mIPSCs) recorded from CA1 pyramidal neurons was significantly smaller in TTX-treated cells (−58 ± 6 pA, n = 7) than in control cells (−91 ± 9 pA, n = 7) (P < 0.01, t test; Fig. 1a) , as has been seen with cultured neurons 17, 18 . The mean mIPSC frequency was unaffected: 3.9 ± 0.9 Hz for control and 3.4 ± 0.5 Hz for TTX-treated cells (P > 0.5, t test; Fig. 1a ). The decrease in mIPSC amplitude is consistent with inactivityinduced homeostasis. If the scaling of mIPSCs applied to all inhibitory synapses, the distributions of mIPSC amplitudes of control and TTX-treated cells would be identical after the control population was adjusted by a scaling factor 18, 19 . Indeed, when each control mIPSC was scaled down (see Online Methods), the adjusted control and TTXtreated mIPSC distributions overlapped almost perfectly (P > 0.9, Kolmogorov-Smirnov test; Fig. 1b) . Thus, chronic TTX scaled down the whole population of mIPSCs rather than just a subset.
We next examined whether the amplitudes of evoked IPSCs (eIPSCs), which are action potential and Ca 2+ dependent, were also reduced by chronic TTX treatment. TTX was removed from the cultures before testing in eIPSC experiments. Using minimal stimulation 20 , we recorded unitary IPSCs (uIPSCs) as a measure of release from putative single axons (Fig. 1c-e) . Because synaptic homeostasis is synapse specific 4, 21, 22 , we segregated different types of inhibitory synapses according to the Ca 2+ channels used for transmission; most inhibitory neurons in hippocampal slices use N-type or P/Q-type Ca 2+ channels but not both 23 . Synapses using P/Q-type Ca 2+ channels were isolated by pre-incubating slice cultures with 500 nM ω-conotoxin GVIA, an irreversible N-type Ca 2+ channel blocker. The control mean amplitude of conotoxin-resistant uIPSCs (excluding failures) was −582 ± 123 pA (n = 6) and was significantly reduced by chronic TTX treatment to −183 ± 17 pA (n = 5) (P < 0.02, t test; Fig. 1c,e) . Similarly, in slices pre-incubated with 300 nM ω-agatoxin IVA (irreversible P/Q type Ca 2+ channel blocker), the mean amplitude of uIPSCs (excluding failures) was decreased by chronic inactivity from −442 ± 48 pA (n = 5, control) to −196 ± 46 pA (n = 6, TTX treated) (P < 0.01, t test; Fig. 1d,e) . The decreases in amplitudes of mIPSCs and uIPSCs both conformed to conventional homeostatic scaling induced by inactivity.
Network excitability, a target for homeostatic control, is determined in part by ongoing GABA release: mIPSCs and spike-driven spontaneous IPSCs (sIPSCs). We measured sIPSC frequency, again separating conotoxin-and agatoxin-resistant synapses. After recording a mixture of mIPSCs and sIPSCs, only mIPSCs were recorded from the same cell in 0.5 µM TTX. The mIPSC frequency was subtracted from the sum of the mIPSCs and sIPSCs to obtain the sIPSC frequency ( Fig. 2a-c) . For conotoxin-resistant synapses, the sIPSC frequency of TTX-treated neurons (0.07 ± 0.03 Hz, n = 5) was lower than that of controls (0.26 ± 0.05 Hz, n = 6) (P < 0.02, t test; Fig. 2a,c) , as expected for conventional homeostatic downregulation of inhibitory synapses. For agatoxin-resistant synapses, however, activity deprivation increased the sIPSC frequency from 0.10 ± 0.04 Hz (five control cells) to 0.74 ± 0.11 Hz (five TTX-treated cells) (P < 0.0005, t test; Fig. 2b,c) .
Because the increased frequency of agatoxin-resistant sIPSCs was unexpected, we asked whether other properties of Ca 2+ -dependent GABA release are also at variance with conventional synaptic homeostasis. Ca 2+ -dependent transmission is governed by P r , which can be assessed with short-term plasticity or paired-pulse ratio (PPR); generally, P r is inversely related to PPR. To measure P r , we evoked IPSCs by delivering three stimuli at 20 Hz to CA1 stratum pyramidale. At conotoxin-resistant synapses, eIPSC depression in control cells (n = 6) was similar to that in TTX-treated cells (n = 6) (P > 0.2, twoway ANOVA; Fig. 2d ), suggesting that P r is unaltered by chronic inactivity. In contrast, agatoxin-resistant eIPSCs showed greater depression in TTX-treated neurons (n = 24) than in control cells (n = 30) (P < 0.001 at each eIPSC number, Bonferroni t test after two-way ANOVA; Fig. 2e ). The amplitude of the third eIPSC, normalized to the first, was 53 ± 2% in control and 38 ± 1% in TTX-treated cells. This indicates that P r actually increased at the agatoxin-resistant synapses. We verified the changes in P r with an independent method by analyzing the coefficient of variation of uIPSCs (Supplementary Fig. 1 ).
In hippocampus, one of the major differences between agatoxinresistant and conotoxin-resistant GABAergic synapses is that only the former possess CB1Rs 24 . We confirmed that the conotoxinresistant synapses were insensitive to depolarization-induced suppression of IPSC (DSI), a short-term synaptic plasticity mediated by endocannabinoid (Supplementary Fig. 2 ). To account for the increase in basal P r found specifically at agatoxin-resistant, CB1R-positive synapses, we hypothesized that the chronic inactivity might reduce a persistent (tonic) endocannabinoid action and diminish basal CB1R activation. a r t I C l e S
Activity deprivation reduces basal activation of CB1R
To test this hypothesis, we first determined whether tonic activation of CB1R is affected by TTX treatment. If the basal CB1R activation, a tonic brake on GABA release, is lowered by inactivity, a CB1R antagonist would increase eIPSC amplitude in TTX-treated cells to a lesser extent than in control cells. In this and subsequent eIPSC recordings, slices were pre-incubated with 300 nM ω-agatoxin IVA for 15-30 min to isolate CB1R-positive terminals. In control cells, CB1R antagonist (either 2 µM SR141716 or 2 µM AM251) enhanced eIPSC amplitudes by 66 ± 10% (n = 13) but only by 19 ± 2% in TTX-treated cells (n = 12) (Fig. 3a) . The effects of SR141716 (n = 7 for both control and TTX-treated groups) were not significantly different from those of AM251 (n = 6 for control and 5 for TTX) (P > 0.5, t tests; Fig. 3a) ; thus, the data obtained with the two antagonists were pooled. The similarity of effects of the two CB1R antagonists indicates that they were specifically mediated by CB1Rs (Supplementary Fig. 3 ).
The significantly smaller effect of CB1R antagonists in TTX-treated cells (P < 0.01, t test) suggests that the tonic activation of CB1R was diminished by chronic inactivity.
To distinguish between the CB1R-antagonist and inverse-agonist effects of SR141716 and AM251, we removed Ca 2+ from the pipette solution while keeping the concentration of free EGTA at 1.7 mM (same free EGTA as in Fig. 3a) to prevent tonic release of endocannabinoids 25 , without interfering with CB1Rs. With this zero-Ca 2+ pipette solution, SR141716 (2 µM) failed to increase the eIPSC amplitude (107 ± 5% of baseline, n = 7, P > 0.4, paired t test ; Fig. 3b) ; if SR141716 had increased eIPSCs by an inverse-agonist action, the effect would have persisted. We conclude that SR141716 increases eIPSCs by antagonizing CB1Rs that are persistently activated by endocannabinoid binding. This result also indicates that the tonic CB1R activation occurs via endocannabinoids released only from the recorded postsynaptic pyramidal cell and not those from other cells.
Because the coefficient of variation (CV) of eIPSC amplitudes is a presynaptic property, the CV −2 would increase if a presynaptic mechanism increased the eIPSC amplitude 26 . Analysis of the changes in CV −2 and eIPSC amplitudes caused by CB1R antagonists implied that the drugs act presynaptically (Fig. 3c) . We also examined this with PPR. If an increase in eIPSC amplitudes is caused by presynaptic enhancement of P r , increases in eIPSCs should be proportional to increases in PPR −1 , as P r is inversely related to PPR. We evoked three IPSCs at 20 Hz and used the third eIPSC amplitude (IPSC3), normalized to the first eIPSC (IPSC1), to calculate PPR3 (IPSC3/IPSC1). The larger increase in eIPSC was accompanied by a larger increase in PPR3 −1 (representing P r ) in control cells than in TTX-treated cells (Fig. 3d) . This result suggests that the increase in eIPSC amplitudes caused by CB1R antagonists was mediated by a presynaptic mechanism, probably an increase in P r . Finally, if tonic activation of CB1R determines the basal P r of GABAergic synapses, the effect of CB1R antagonists will be larger at synapses with lower P r (these synapses will be more depressed by endocannabinoid tone). Indeed, the degree of eIPSC enhancement induced by CB1R antagonists was proportional to PPR3, with a low PPR3 value implying a high basal P r (Fig. 3e) , indicating that the basal P r is largely influenced by tonic activation of CB1R. Additional evidence presented below argues that the difference in the ability of CB1R antagonists to increase eIPSCs is attributable to alterations in the endocannabinoid system, rather than other potential effects of chronic inactivity (see Discussion).
One possible cause for the reduction in tonic CB1R activation is that the receptors could have become less responsive to endocannabinoids because of changes in receptor density or sensitivity. To assess CB1R responsiveness, we measured eIPSC suppression caused by WIN55212-2, a synthetic agonist resistant to cellular uptake. In controls, WIN55212-2 reduced the eIPSC amplitude to 46 ± 5% of baseline at 5 nM (n = 7), 28 ± 5% at 20 nM (n = 7) and 9 ± 2% at 200 nM (n = 7) (Fig. 4a,b) . The effect of WIN55212-2 in TTX-treated cells was not significantly different at any concentration from that in control cells (P > 0.4 at each concentration, t tests). WIN55212-2 suppressed the TTX-treated eIPSCs to 50 ± 9% (5 nM, n = 7), 23 ± 5% (20 nM, n = 6) and 10 ± 3% (200 nM, n = 7) of the baseline. Thus, CB1R responsiveness is not altered by activity deprivation. (Fig. 3b) 25 , we hypothesized that chronic TTX might reduce the postsynaptic basal intracellular Ca 2+ concentration ([Ca 2+ ] in ).
When measured with Fura-2 (200 µM), the mean basal [Ca 2+ ] in in the somata of control pyramidal neurons was 40 ± 7 nM (n = 9), similar to that seen in TTX-treated cells (31 ± 4 nM, n = 8) (P > 0.2, t test; Fig. 5a,b) . This implies that one factor in tonic endocannabinoid production, basal [Ca 2+ ] in , is not affected by chronic TTX but does not rule out other changes, such as Ca 2+ sensitivity of synthetic enzyme(s).
To assay the Ca 2+ sensitivity of endocannabinoid production, we elevated [Ca 2+ ] in by depolarizing pyramidal cells to 0 mV for 500 ms while monitoring endocannabinoid action. There was no difference in the peak [Ca 2+ ] in (5-s time window) following depolarization in control (116 ± 20 nM) and TTX-treated cells (111 ± 12 nM) (P > 0.8, t test; Fig. 5a,b) . However, our 1-Hz sampling rate might have missed a difference in [Ca 2+ ] in in the first 1-s bin. The effect of endocannabinoid after the depolarization was assayed as DSI, simultaneously with Ca 2+ imaging (Fig. 5c) . DSI was quantified by integrating the suppression of eIPSC amplitudes from 6 to 144 s after the depolarization. The DSI induced by 500-ms depolarization was not significantly different between control (890 ± 220%·s, n = 9) and TTX-treated cells (1,270 ± 320%·s, n = 8) (P > 0.3, t test). Peak suppression of the eIPSC, taken as the average of the second and third eIPSCs after depolarization, was also similar: 25 ± 6% reduction in control and 34 ± 5% in TTXtreated cells (P > 0.2, t test). When greater Ca 2+ influx was induced in the postsynaptic cells with longer (5 s) depolarizations, DSI integrated over 4 min still did not show any difference (Fig. 5d,e) : 5,150 ± 400%·s in 14 control cells and 4,250 ± 620%·s in 11 TTX-treated cells (P > 0.2, t test). Because DSI is mediated by 2-AG 10 , this result indicates that the Ca 2+ sensitivity of 2-AG production was not affected by chronic inactivity. In conclusion, the activity deprivation does not affect basal [Ca 2+ ] in , depolarization-induced [Ca 2+ ] in elevation or Ca 2+ dependence of 2-AG mobilization.
Tonic uptake and degradation of anandamide are enhanced Lack of changes in CB1R, or endocannabinoid production and release, prompted us to examine whether tonic uptake and degradation of endocannabinoid were altered by chronic TTX. Chronic inactivity might enhance uptake of basal endocannabinoid and thereby reduce endocannabinoid tone. This predicts that inhibition of transport by AM404 would cause a greater increase in endocannabinoid tone in TTX-treated slices than in control slices. As predicted, the eIPSC suppression induced by 20 µM AM404 was significantly larger in TTX-treated neurons (27 ± 7%, n = 7) than in control cells (2 ± 2% increase, n = 6) (P < 0.005, t test; Fig. 6a ). This result suggests that the chronic inactivity facilitates tonic endocannabinoid uptake. a r t I C l e S If 2-AG is tonically released and chronic inactivity increases the rate of 2-AG uptake, then DSI decay would be accelerated, as the 2-AG released during DSI would be inactivated more rapidly [27] [28] [29] . In contrast with this prediction, the DSI time courses were not different between the two groups ( Fig. 5c-e) and the similarity persisted when 2-AG uptake was blocked by AM404 (Fig. 6b) . We confirmed that AM404 effectively blocked 2-AG uptake because AM404 prolonged the DSI decay rate (P < 0.002, t tests between AM404 and no AM404; Fig. 6c) . Nevertheless, DSI integrals after 5-s depolarizations were indistinguishable between control (8,990 ± 670%·s, n = 5) and TTX-treated (9,120 ± 110%·s, n = 5) groups in the presence of 20 µM AM404 (P > 0.9, t test; Fig. 6b,c) . Thus, neither production nor uptake of 2-AG during DSI is altered by chronic inactivity.
Because activity deprivation affected tonic endocannabinoid actions, but not 2-AG signaling, we postulated that anandamide, rather than 2-AG, is tonically released. Although the endocannabinoid transporter has the same binding affinity for 2-AG and anandamide, the driving force for uptake of a given endocannabinoid can be selectively increased if intracellular degradation of that endocannabinoid is enhanced 30 . If anandamide accounts for the tonic endocannabinoid effects, the activity of its degradative enzyme (fatty acid amide hydrolase, FAAH), the driving force for anandamide uptake, might be higher in TTX-treated cells than in control cells. This hypothesis predicts that blockade of FAAH would cause greater accumulation of extracellular anandamide and, consequently, a greater CB1R-dependent eIPSC suppression in activity-deprived cells than in control cells. To test this, we measured eIPSC reduction caused by 1 µM URB597, a very specific and potent inhibitor of FAAH 31 . As predicted, the URB597-mediated depression of eIPSC was significantly larger in TTX-treated cells (44 ± 6%, n = 7) than in controls (15 ± 8%, n = 6) (P < 0.02, t test; Fig. 6d) . URB597 had no effect on 2-AG signaling, as it did not affect DSI (Supplementary Fig. 4) 27, 28 . These results suggest that chronic inactivity boosts FAAH activity, which in turn causes stronger uptake of tonically released anandamide.
We next tested whether AM404 and URB597 suppressed eIPSCs by a presynaptic mechanism. Because the eIPSC reduction caused by AM404 was not significantly different from that caused by URB597 (P > 0.05, t tests) in either control or TTX-treated cell, we pooled the data from AM404 and URB597 experiments (Fig. 6e,f) . We first plotted changes in CV −2 caused by AM404 or URB597 against changes in eIPSC amplitudes. Indeed, eIPSC amplitudes and CV −2 decreased proportionately (Fig. 6e) , which is consistent with a presynaptic mechanism. Next, we compared PPR3 −1 changes in control and TTXtreated neurons. In TTX-treated cells, AM404 or URB597 caused larger decreases in both eIPSC amplitude and PPR3 −1 than they did in control cells (Fig. 6f) , suggesting that they act presynaptically, potentially by decreasing P r . In the third test, we asked whether AM404 and URB597 suppressed eIPSCs via presynaptic CB1Rs. In the presence of SR14176 (2 µM), a cocktail of AM404 (20 µM) and URB597 (1 µM) did not reduce eIPSC amplitudes (100 ± 3% of baseline, n = 6; Fig. 6g ) (P > 0.5, paired t test), indicating that the effects of these drugs were mediated by CB1Rs.
The effect of URB597 (Fig. 6d) suggests that FAAH activity was increased. We further assayed FAAH activity by bath-applying anandamide, a substrate for FAAH, at a submaximal concentration (720 nM) while monitoring eIPSC amplitudes. We used the zero-Ca 2+ pipette solution (as in Fig. 3b ) to prevent formation of endogenous anandamide and leave FAAH unoccupied. If FAAH were more active, for example, in TTX-treated cells, then bath-applied anandamide would be less effective in suppressing eIPSCs. The reduction in eIPSC caused by 720 nM anandamide was significantly smaller in TTX-treated cells (22 ± 6%, n = 5) than in controls (46 ± 6%, n = 5) (P < 0.05, t test; Fig. 6h ), suggesting that FAAH is more active in TTX-treated cells.
Deafferentation also decreases endocannabinoid tone
To simulate a more realistic model of activity loss than chronic TTX, we imposed neuronal inactivity by deafferentation, which may be more relevant to in vivo pathology. Afferent excitation of the CA1 region was reduced by the surgical removal of the CA3 area, the major source of excitatory inputs to CA1. In control slices, a cut was made between CA1 and subiculum, which is on the efferent side of CA1 (Fig. 7a) . Evoked IPSCs were recorded from CA1 pyramidal neurons 5-7 d after the cut. We carried out a series of experiments that were similar to those described above (Fig. 3) to examine whether chronic deafferentation induced changes similar to those caused by TTX treatment.
As in TTX-treated slices, eIPSCs in deafferented slices showed more pronounced short-term depression than those in control slices (Fig. 7b) . The mean PPR3 was 49 ± 3% (n = 7) in control cells and 39 ± 2% (n = 6) in deafferented cells (P < 0.01, Bonferroni t test a r t I C l e S after two-way ANOVA). In addition, SR141716 (2 µM) enhanced eIPSCs in deafferented neurons by 13 ± 4% (n = 6), which was significantly smaller than in control cells (49 ± 9%, n = 7) (P < 0.005, t test; Fig. 7c ). Finally, we observed that basal P r , as represented by PPR3, was related to the basal activation of CB1Rs (Fig. 7d) . These results indicate that deafferentation, as with chronic TTX, reduced endocannabinoid tone. Additional tests, analogous to those carried out earlier for TTX-treated slices, revealed that the effects of SR141716 were mediated presynaptically (Fig. 7e,f) . These results suggest that the endocannabinoid tone can be regulated by pathologically relevant inactivity such as neurodegeneration and support the use of chronic TTX treatment as a model for studying the mechanisms involved.
Role of the increased GABAergic P r in network integration
The roles of the reduced endocannabinoid tone in maintaining network activity should be interpreted in conjunction with its effects on excitatory synapses, as CB1Rs are also expressed on glutamatergic terminals at a low level 12, 32 . We therefore examined the effect of SR141716 on evoked excitatory postsynaptic currents (eEPSCs). Bath-applied 2 µM SR141716 did not change the amplitudes of eEPSCs in either control (6 ± 6% reduction, n = 5) or TTX-treated cells (8 ± 3% reduction, n = 5) (P > 0.09, paired t test each for control or TTX-treated group; Fig. 8a,b) . This indicates that the basal anandamide does not participate in homeostatic scaling of eEPSCs. We next examined changes in short-term plasticity of eEPSCs. In control cells (n = 5), EPSCs evoked three times at 20 Hz initially displayed a slight facilitation (109 ± 7% of the first EPSC) and then a mild depression (87 ± 7%) (Fig. 8c) . In contrast, eEPSCs in TTXtreated neurons (n = 8) were depressed more than control eEPSCs (83 ± 3% and 63 ± 4% for the second and third EPSCs, respectively; P < 0.005 at each eEPSC number, Bonferroni t-test after two-way ANOVA). This result indicates that glutamatergic P r is also increased after chronic inactivity but independently of the tonic anandamide actions, as it was not altered by SR141716 in either TTX-treated a r t I C l e S or control groups (P > 0.8, paired t tests; Fig. 8d ). Although the increase in P r of CB1R-positive inhibitory synapses after activity deprivation seems contrary to conventional homeostatic scaling, the consequent enhancement of GABAergic short-term depression (Fig. 2e) will dampen excitatory transmission to a lesser degree at high-frequency transmission (20 Hz). Such a low pass-filtering effect for IPSCs would be beneficial because glutamatergic transmission also suffers from more rapid depression as a result of higher P r .
DISCUSSION
Our results indicate that a decrease in anandamide tone, resulting from increased anandamide degradation, is responsible for synapse-specific adaptation of GABA release from CB1R-positive interneurons in the activity-deprived hippocampus (Supplementary Fig. 5 ). The reduced sizes of mIPSCs and uIPSCs (Fig. 1) meet the conventional compensatory homeostatic demand for weakened GABAergic synapses and appeared to occur at all of the GABAergic synapses onto pyramidal cells. However, a specific set of CB1R-positive, inhibitory synapses was selectively strengthened by an increase in basal P r . Targeting a specific subset of synapses is a critical step in maintaining complex circuits and is accomplished by regulation of anandamide tone.
Anandamide as a tonically released endocannabinoid
Although 2-AG mediates major forms of endocannabinoid-dependent synaptic plasticity, such as DSI and GABAergic long-term depression in the hippocampus 10, 27, 33 , the roles of endogenous anandamide in hippocampal synaptic regulation are largely unknown. However, endogenous anandamide has often been implicated in behavioral roles, such as emotion 31 and learning 34 . The lack of evidence, however, at the cellular level for anandamide-mediated effects has created a major gap in our understanding of its role in behavior. Our data not only help fill in the gap, but also indicate that the two endocannabinoids can be released from cells under different circumstances and are subject to different types of regulation. N-acylphosphatidylethanolamine-hydrolyzing phospholipase D (NAPE-PLD), a widely studied synthetic enzyme for anandamide 35 , is located in axons and axon terminals, not in somata or dendrites, in hippocampal CA1 (ref. [36] [37] [38] . Because our results (Fig. 3b) indicate that anandamide acts as a tonic retrograde messenger, it must be produced in the postsynaptic soma or dendrites. The apparent location of a r t I C l e S NAPE-PLD probably excludes it as the synthase of basal anandamide. Indeed, ablation of the Napepld gene does not affect tonic levels of anandamide in the brain 39 . However, final exclusion of NAPE-PLD as a candidate synthase will depend on an unequivocal demonstration of its location (for example, refs. [36] [37] [38] . The elucidation of the synthetic pathway for basal anandamide 35 will require localization of the enzymes involved and/or development of specific pharmacological tools. Some unique properties make anandamide seem especially appropriate for exerting tonic action on CB1R. First, anandamide is a partial agonist of CB1R and is therefore less efficacious than full agonists 40, 41 . This property may allow other agonists with high efficacy, such as 2-AG and WIN55212-2, to act in their full capacity, which would explain why the effects of WIN55212-2 (Fig. 4) and DSI (Fig. 5) were unaltered. Second, anandamide desensitizes CB1R less than 2-AG does 40 . By minimizing constitutive desensitization, the endocannabinoid system can preserve its responsiveness to activitydependent phasic stimulation. A lingering question is whether the amount of anandamide produced is also less in activity-deprived neurons. Our quantitative analysis, which was based on the comparison of the actions of CB1R antagonists and AM404 in control and chronic TTX tissue suggested that the total amount of anandamide tonically released is not greatly affected by activity deprivation ( Supplementary  Fig. 6 ). Nevertheless, direct investigation of this issue is required.
In contrast with these results (Fig. 6d) , we previously reported that URB597 had no effect on eIPSCs in acute hippocampal slices that were not pre-incubated with ω-agatoxin IVA 27 . This discrepancy could be attributed to the purity of the endocannabinoid bioassay, that is, exclusion of CB1R-negative terminals with ω-agatoxin IVA. When we preincubated acute hippocampal slices with ω-agatoxin, 1 µM URB597 also suppressed the eIPSC by 21 ± 5% (n = 5; Supplementary Fig. 7) . Thus, the mild anandamide tone and the basal role of FAAH are not culture-specific phenomena but are present in more physiological, acute slices. The magnitude of the eIPSC increase (66%; Fig. 3a) caused by CB1R antagonist was larger than that reported with acute hippocampal slices (13%) 42 . The difference might again be a result of the use of ω-agatoxin. In fact, when CB1R-expressing presynaptic neurons are isolated by the paired recording method, application of a CB1R antagonist can markedly increase basal IPSC amplitude 25, 43 . Another possibility is that the higher temperature 42 may facilitate anandamide degradation, lowering its tone. However, we found that when control slice cultures were kept at 31 °C during recording, bath-applied SR141716 (2 µM) also increased the amplitude of eIPSC by 35 ± 9% (n = 5; Supplementary Fig. 8 ). This indicates that the tonic anandamide action is not an artifact of experimental conditions. Nevertheless, slice cultures are distinct from in vivo systems; thus, the relevance of our study in living organism needs to be more carefully examined. In dissociated cultures of hippocampal neurons, tonic FAAH activity is absent and 2-AG is the dominant basal endocannabinoid 44 . This could be related to the immaturity of dissociated cultures, as the expression of FAAH in CA1 of rat hippocampus increases from postnatal day 8 to 22 (ref. 45) and the basal anandamide level also rises with age 46 . Our slice cultures were more mature in terms of animal age at culturing and days in vitro than typical dissociated cultures.
Endocannabinoid tone as a major determinant of basal P r Our data suggest that, in activity-deprived neurons, the reduced tonic activation of CB1R is responsible for the enhanced basal P r of CB1R-positive GABAergic synapses (Fig. 3e) . Alternatively, it is conceivable that chronic TTX treatment increased the P r independently of any changes in tonic endocannabinoid actions. If the P r of TTX-treated GABAergic synapses was already high, tonic CB1R activation would be less effective at suppressing release (ceiling effect) and SR141716 would therefore be less effective at enhancing it. To distinguish between a ceiling effect and a tonic endocannabinoid effect, we considered the critical prediction of the ceiling model: an increase in GABAergic P r must decrease the ability of tonically released endocannabinoid to suppress eIPSCs 43, 47 . Therefore, the ceiling effect model predicts that the ability of CB1R activation to suppress eIPSCs will be decreased in TTX-treated cells.
We tested this prediction using direct application of the CB1R agonist WIN55212-2 and by inducing phasic endocannabinoid actions with depolarization (that is, DSI). The results of both tests (Figs. 4 and 5) were unambiguous; contrary to the predictions of the ceiling effect model, there was no change in DSI or the ability of WIN55212-2 to suppress eIPSCs. Thus, any underlying endocannabinoid-independent increase in P r must have been insufficient to mask the inhibitory effects of CB1R activation. Because it fails this critical test, the ceiling effect model cannot account for our observations and we conclude that the simplest explanation for the data remains the tonic endocannabinoid model.
Functional importance
A homeostatic increase in network excitability often faces challenges in balancing excitation and inhibition [2] [3] [4] , especially when GABAergic synapses are globally scaled down. A way to control the risk might be to upregulate a subpopulation and/or a certain property of GABAergic synapses, for example, strengthening the P r of only a part of the interneuron population. This would help the system prevent the deleterious effects of widespread unchecked disinhibition. Indeed, our results suggest that the overall downregulation of inhibitory wiring, achieved by global decreases in IPSC amplitudes, may be partly counterbalanced by increasing the P r of CB1R-positive synapses. It is therefore possible that CB1R-positive interneurons might be important for stabilizing the network during chronic inactivity.
Another advantage of increasing GABAergic P r during chronic inactivity is that two opposite effects can be achieved: an increase in synaptic inhibition at low stimulation frequencies and greater short-term depression at high frequencies (≥ 20 Hz). The increased short-term depression turns the connection into a low-pass filter, as high-frequency inhibitory transmission rapidly fades out. If inhibitory synaptic transmission depresses quickly during fast spiking, concomitant excitatory connections will be less shunted by GABA. Therefore, the net effect of elevated GABAergic P r would favor excitation, consistent with homeostatic boosting of network gain, when circuits are repetitively activated 48 .
We found that endocannabinoid tone was reduced by chronic inactivity and that this phenomenon may be relevant to pathological situations, as modeled with deafferentation (Fig. 7) . Damage to CA3 or lesions of Schaffer collaterals are often used as models for brain injury, as they induce changes similar to those of in vivo brain injury 49 . It is therefore possible to conjecture from our results that basal anandamide tone could be diminished following brain injury in vivo. In this case, a variety of cellular functions would be affected. Aforementioned contributions to circuit stabilization and synaptic integration seem to be favorable in terms of network homeostasis, but reduced anandamide tone could also have detrimental effects given the various beneficial roles of endocannabinoids, such as neuroprotection 50 . For example, after brain injury, demand for endocannabinoid-mediated neuroprotection would be elevated, but an inactivity-induced decrease in endocannabinoid tone could prevent the demand from being met. In this case, the lowered tonic level of endocannabinoid would exacerbate the progress of neurodegeneration.
